Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports von Evens, A.M., Jovanovic, B.D., Su, Y.-C., Raisch, D.W., Ganger, D., Belknap, S.M., Dai, M.-S., Chiu, B.-C. C., Fintel, B., Cheng, Y., Chuang, S.-S., Lee, M.-Y., Chen, T.-Y., Lin, S.-F., Kuo, C.-Y.

Volltext

PMD73 Comparisons of Anaphylactoid Reactions Associated With Different Gadolinium Products and Iodinated Contast Media Using the FDA's Adverse Event Reporting System von Raisch, D.W, Garg, V, Samaras, A.T, Saddleton, E.E, Lauman, A.E, Mckoy, J, Belknap, S.M, West, D

Volltext

Reporting of serious adverse events during cancer clinical trials to the institutional review board: An evaluation by the R esearch on A dverse D rug events A nd R eports (RADAR) p... von Belknap, S.M., Georgopoulos, C.H., Lagman, J., Weitzman, S.A., Qualkenbush, L., Yarnold, P.R., Edwards, B.J., McKoy, J.M., Trifilio, S.M., West, D.P.

Volltext

Reporting of serious adverse events during cancer clinical trials to the institutional review board: An evaluation by the Research on Adverse Drug events And Reports (RADAR) projec... von Belknap, S.M., Georgopoulos, C.H., Lagman, J., Weitzman, S.A., Qualkenbush, L., Yarnold, P.R., Edwards, B.J., McKoy, J.M., Trifilio, S.M., West, D.P.

Volltext

Biomonitoring Equivalents for cyanide von Kirman, C.R., Belknap, A.M., Webster, A.F., Hays, S.M.

Volltext